SNMMI disagrees with CMS PET decision
Article Thumbnail ImageJuly 9, 2013 -- The Society of Nuclear Medicine and Molecular Imaging (SNMMI) expressed its disappointment with the July 3 draft decision from the U.S. Centers for Medicare and Medicaid Services (CMS) regarding the use of beta-amyloid PET imaging agents.

To get access to this article and all of the content on, create a free account or sign-in now.

Member Sign In:
  MemberID or E-mail Address:

New Members

Becoming a Member is FREE!

  • Real-time radiology-specific news
  • Case of the Day and Teaching Files
  • Focused topics digital communities
  • Lively, discussion groups
  • Medical imaging bookstore
  • SalaryScan
  • Job Boards
  • Online CME
  • Bookstore, market reports, more …
  • Conference Calendar
  • User-controlled eNewsletters
  • … registration is FREE and easy!
  • CMS agreed to cover one PET scan to exclude Alzheimer's disease, but only for patients participating in specific clinical studies under a coverage-with-evidence development (CED) program, which grants conditional reimbursement upon collection of specific data.

    SNMMI believes there is sufficient evidence to support immediate, broader coverage, which would change patient management, leading to better health outcomes and helping families make care decisions. The group will soon release an education program for physicians who will refer patients and those who will be reading the scans.

    In addition, SNMMI is developing technical procedure guidelines for ensuring quality in the performance of the PET procedures.

    || About || Advertising || || Bookstore || Breast MRI || Career Center || Case of the Day || Communities || Conferences || Contact Us || ECR News 2014 || Education || Equipment Classifieds || Europe || Facebook || Forums || Home || Links || Marketplace || Middle East || Mobile || Molecular Breast Imaging || New Installations || News in Brief || People in the News || Privacy Policy || RSNA News 2013 || Reference || Salary Survey Results || Trends in Radiology || Twitter || Vendor Connect || Webinars || XML/RSS ||

    Copyright © 2014 All Rights Reserved.